Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Unbilled receivable
Restricted cash, current
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Restricted cash
Operating lease right-of-use assets
Other noncurrent assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable
Accrued expenses and other current liabilities
Operating lease liabilities, current portion
Term loan, current portion
Total current liabilities
Deferred rent, noncurrent portion
Operating lease liabilities, noncurrent portion
Other noncurrent liabilities
Term loan, noncurrent portion
TOTAL LIABILITIES
STOCKHOLDERS’ EQUITY
Common stock, $0.0001 par value; 500,000,000 shares authorized; 47,790,092 and 47,707,691 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively
Common Stock Class Undefined
Total common stock, $0.0001 par value; 500,000,000 shares authorized; 47,790,092 and 47,707,691 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
TOTAL STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support